The First Affiliated Hospital with Nanjing Medical University
This is a Phase II Randomised Controlled Clinical Trial to evaluate the efficacy of auricular acupuncture therapy via the Seirin Pyonex Needles in the prevention of chemotherapy-induced peripheral neuropathy in breast cancer.
Age
18–75
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Patients with breast cancer diagnosed with stage I-III;
Planned to receive 4 cycles of taxane chemotherapy and have not taken neurostable drugs within three months;
18 years old≤ age≤ 75 years old, female;
Subjects voluntarily participate in this trial and sign the informed consent form.
You may not be if
Patients who have had acupuncture treatment in the past;
After examination by a doctor, there is a local infection at or near the acupuncture site, which is not suitable for acupuncture.
Platelets\< 50,000/μL;
Patients with CIPN≥1 grade 1 (NCI-CTCAE);
Peripheral neuropathy or other neuropathic pain caused by diabetes mellitus or other factors related to HIV infection.
Clareo Health | Efficacy of Auricular Acupuncture Therapy in the Prevention of CIPN in Breast Cancer
